Forward Pharma A Performance
| FWPDelisted Stock | USD 2.56 0.00 0.00% |
The firm shows a Beta (market volatility) of -0.16, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Forward Pharma are expected to decrease at a much lower rate. During the bear market, Forward Pharma is likely to outperform the market. Forward Pharma A right now shows a risk of 0.0%. Please confirm Forward Pharma A jensen alpha, value at risk, as well as the relationship between the Value At Risk and skewness , to decide if Forward Pharma A will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Forward Pharma A has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Forward Pharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Begin Period Cash Flow | 79.1 M |
Forward |
Forward Pharma Relative Risk vs. Return Landscape
If you would invest 256.00 in Forward Pharma A on September 2, 2024 and sell it today you would earn a total of 0.00 from holding Forward Pharma A or generate 0.0% return on investment over 90 days. Forward Pharma A is generating negative expected returns assuming volatility of 0.0% on return distribution over 90 days investment horizon. In other words, 0% of stocks are less volatile than Forward, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Forward Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Forward Pharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Forward Pharma A, and traders can use it to determine the average amount a Forward Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| FWP |
Based on monthly moving average Forward Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Forward Pharma by adding Forward Pharma to a well-diversified portfolio.
Forward Pharma Fundamentals Growth
Forward Stock prices reflect investors' perceptions of the future prospects and financial health of Forward Pharma, and Forward Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Forward Stock performance.
| Return On Equity | -0.0083 | |||
| Return On Asset | -0.0342 | |||
| Current Valuation | (43.04 M) | |||
| Shares Outstanding | 7.09 M | |||
| Price To Earning | 0.13 X | |||
| Price To Book | 0.31 X | |||
| EBITDA | (1.89 M) | |||
| Cash And Equivalents | 70.77 M | |||
| Cash Per Share | 10.08 X | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | 8.76 X | |||
| Cash Flow From Operations | (2.36 M) | |||
| Earnings Per Share | (0.27) X | |||
| Total Asset | 71.41 M | |||
| Retained Earnings | (9.1 M) | |||
| Current Asset | 99.8 M | |||
| Current Liabilities | 6.21 M | |||
About Forward Pharma Performance
Assessing Forward Pharma's fundamental ratios provides investors with valuable insights into Forward Pharma's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Forward Pharma is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma AS was incorporated in 2005 and is headquartered in Copenhagen, Denmark. Forward Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.Things to note about Forward Pharma A performance evaluation
Checking the ongoing alerts about Forward Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Forward Pharma A help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Forward Pharma A is not yet fully synchronised with the market data | |
| Forward Pharma A has a very high chance of going through financial distress in the upcoming years | |
| Reported Net Loss for the year was (1.89 M) with profit before taxes, overhead, and interest of 0. | |
| Forward Pharma A has about 70.77 M in cash with (2.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Forward Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Forward Pharma's stock is overvalued or undervalued compared to its peers.
- Examining Forward Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Forward Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Forward Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Forward Pharma's stock. These opinions can provide insight into Forward Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in Forward Stock
If you are still planning to invest in Forward Pharma A check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Forward Pharma's history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |